FreshRecalls

⚠ Data freshness notice: the most recent refresh of NHTSA was incomplete, so a very recent recall may be missing. Everything shown is accurate as of the last checked time on this page — for anything time-critical, confirm with the official sources linked below.

FDAClass II · Medical device · Recalled July 8, 2026

MEDLINE 111 GRAVITY SET W/3 Needle Free Y-Sites REF DYNDTN0555 Catalog Number recall — BD SWITZERLAND SARL

Hazard: Due to engineering sample labeled "Not for Human Use" being inadvertently shipped it the U.S. market.

Class II: may cause temporary or medically reversible health consequences.

View the official FDA enforcement record (openFDA) ↗

Official recall ID
Z-2654-2026
Brand
BD SWITZERLAND SARL
Classification
Class II
Units affected
50 devices
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Description

MEDLINE 111 GRAVITY SET W/3 Needle Free Y-Sites REF DYNDTN0555 Catalog Number: SAM2461 UDI code: N/A Engineering Sample/Not for Human Use

Affected products

Companies & origin

Recalling firm location
Eysins, N/A, Switzerland
Firm address
Terre Bonne Park A4, Route De Crassier 17, N/A

Identifying details (verbatim from the notice)

Product codes / lots
Catalog Number: SAM2461 REF: DYNDTN0555 UDI code: N/A Lot Number: 25X445
Distribution
U.S.: IL O.U.S: N/A
Firm notified the public via
N/A
FDA event ID
99085
Recall initiated
June 4, 2026
FDA classified
July 2, 2026
FDA report date
July 8, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 23, 2026 at 11:04 PM UTC.

Report a data error on this page